Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Spray for Perineal Laceration Repair
NCT05201313Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Udine
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine 10% oropharyngeal spray in perineal laceration, sponsored by Azienda Ospedaliero-Universitaria di Udine. Started Jan 2022; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
perineal laceration
Beyond the preview
Go deeper on NCT05201313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201313.